pulseline logo

People living with diabetes now have broader access to blood glucose monitoring products in Australia


Diabetes is considered an epidemic in Australia, with 1.7 million Australians living with the condition and a further 280 people diagnosed each day.

“While pharmacy remains the key access point for products that are reimbursed via the National Diabetes Services Scheme (NDSS) and to seek advice, it is evident that many Australians are simply not managing their diabetes effectively and we want to ensure that access is not a barrier,” said Ms Jane Crowe, General Manager, Roche Diabetes Care Australia.

“We are committed to innovation, not only in our product development, but also in ways in which consumers can access them. Given this range is not reimbursed via the NDSS, no form is required to purchase the products, enabling us to establish the partnership with Woolworths and broaden availability.

“As the market leader in diabetes monitoring, we are passionate about understanding the needs of people with diabetes and offering them broad access to encourage regular self-management,” said Ms Crowe.

Roche Diabetes Care has been pioneering innovative diabetes technologies and services for more than 40 years. Being a global leader in integrated personalised diabetes management, we work every day to support people with diabetes and those at risk to achieve more time in their target range and experience true relief from the daily therapy routines.

Under the brand Accu-Chek and in collaboration with partners, Roche Diabetes Care creates value by providing integrated solutions to enable optimal personalised diabetes management.


Related Stories

Featured, Future of MedTech

You have subscribed